Ubs Group Ag Ptc Therapeutics, Inc. Transaction History

Ubs Group Ag

$400 Billion
Q2 2024

A detailed history of Ubs Group Ag transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 136,761 shares of PTCT stock, worth $4.79 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

136,761

Previous 225,460 39.34%

Holding current value

$4.79 Million

Previous $6.56 Million 36.23%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$24.69 - $40.12 $2.19 Million - $3.56 Million	-88,699 Reduced 39.34%	136,761 $4.18 Million
Q1 2024 May 13, 2024	SELL	$24.15 - $31.95 $1.53 Million - $2.02 Million	-63,288 Reduced 21.92%	225,460 $6.56 Million
Q4 2023 Feb 09, 2024	BUY	$18.07 - $29.37 $3.81 Million - $6.19 Million	210,883 Added 270.83%	288,748 $7.96 Million
Q3 2023 Nov 09, 2023	SELL	$22.41 - $41.99 $317,908 - $595,670	-14,186 Reduced 15.41%	77,865 $1.74 Million
Q2 2023 Aug 11, 2023	BUY	$40.4 - $59.1 $615,251 - $900,033	15,229 Added 19.82%	92,051 $3.74 Million
Q1 2023 May 12, 2023	SELL	$38.16 - $48.86 $1.22 Million - $1.57 Million	-32,046 Reduced 29.44%	76,822 $3.72 Million
Q4 2022 Feb 08, 2023	BUY	$33.53 - $54.79 $2.62 Million - $4.28 Million	78,107 Added 253.92%	108,868 $4.16 Million
Q3 2022 Nov 10, 2022	SELL	$41.85 - $53.85 $1.13 Million - $1.46 Million	-27,031 Reduced 46.77%	30,761 $1.54 Million
Q2 2022 Aug 10, 2022	SELL	$25.6 - $45.23 $2.15 Million - $3.81 Million	-84,177 Reduced 59.29%	57,792 $2.32 Million
Q1 2022 May 16, 2022	BUY	$33.33 - $44.6 $409,859 - $548,446	12,297 Added 9.48%	141,969 $5.3 Million
Q4 2021 Feb 14, 2022	BUY	$35.36 - $41.86 $2.36 Million - $2.8 Million	66,850 Added 106.41%	129,672 $5.16 Million
Q3 2021 Nov 15, 2021	BUY	$37.01 - $44.74 $2.32 Million - $2.81 Million	62,729 Added 67450.54%	62,822 $2.34 Million
Q2 2021 Aug 13, 2021	SELL	$37.95 - $49.37 $1.25 Million - $1.62 Million	-32,879 Reduced 99.72%	93 $4,000
Q1 2021 May 12, 2021	BUY	$46.8 - $68.92 $1.53 Million - $2.25 Million	32,588 Added 8486.46%	32,972 $1.56 Million
Q4 2020 Feb 11, 2021	BUY	$47.96 - $67.64 $4,316 - $6,087	90 Added 30.61%	384 $23,000
Q3 2020 Nov 12, 2020	SELL	$45.41 - $57.07 $216,560 - $272,166	-4,769 Reduced 94.19%	294 $14,000
Q2 2020 Jul 31, 2020	SELL	$42.56 - $54.98 $2.84 Million - $3.67 Million	-66,826 Reduced 92.96%	5,063 $257,000
Q1 2020 May 01, 2020	BUY	$32.37 - $59.36 $457,711 - $839,350	14,140 Added 24.49%	71,889 $3.21 Million
Q4 2019 Feb 14, 2020	SELL	$32.22 - $50.07 $929,772 - $1.44 Million	-28,857 Reduced 33.32%	57,749 $2.77 Million
Q3 2019 Nov 14, 2019	BUY	$33.82 - $48.17 $2.62 Million - $3.73 Million	77,339 Added 834.56%	86,606 $2.93 Million
Q2 2019 Aug 14, 2019	BUY	$35.42 - $45.0 $14,557 - $18,495	411 Added 4.64%	9,267 $417,000
Q1 2019 May 14, 2019	SELL	$28.09 - $39.49 $2.09 Million - $2.94 Million	-74,541 Reduced 89.38%	8,856 $334,000
Q4 2018 Feb 14, 2019	BUY	$29.83 - $46.51 $1.59 Million - $2.48 Million	53,298 Added 177.08%	83,397 $2.86 Million
Q3 2018 Nov 14, 2018	BUY	$33.9 - $47.77 $613,183 - $864,063	18,088 Added 150.6%	30,099 $1.42 Million
Q2 2018 Aug 14, 2018	BUY	$25.7 - $47.88 $44,024 - $82,018	1,713 Added 16.63%	12,011 $405,000
Q1 2018 May 15, 2018	SELL	$17.46 - $32.59 $1.14 Million - $2.14 Million	-65,565 Reduced 86.43%	10,298 $279,000
Q4 2017 Feb 14, 2018	BUY	$15.14 - $20.89 $183,951 - $253,813	12,150 Added 19.07%	75,863 $1.27 Million
Q3 2017 Nov 14, 2017	BUY	$16.81 - $21.61 $609,816 - $783,945	36,277 Added 132.22%	63,713 $1.28 Million
Q2 2017 Aug 14, 2017	BUY	N/A	3,123 Added 12.84%	27,436 $503,000
Q1 2017 Nov 14, 2017	BUY	N/A	24,313	24,313 $239,000

Others Institutions Holding PTCT

# of Institutions

216

Shares Held

79.2M

Call Options Held

122K

Put Options Held

212K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.51B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account